ATE209256T1 - Schnelle krebs-diagnose - Google Patents

Schnelle krebs-diagnose

Info

Publication number
ATE209256T1
ATE209256T1 AT98912475T AT98912475T ATE209256T1 AT E209256 T1 ATE209256 T1 AT E209256T1 AT 98912475 T AT98912475 T AT 98912475T AT 98912475 T AT98912475 T AT 98912475T AT E209256 T1 ATE209256 T1 AT E209256T1
Authority
AT
Austria
Prior art keywords
cancer diagnosis
cancer
quick
quick cancer
diagnosis
Prior art date
Application number
AT98912475T
Other languages
English (en)
Inventor
Ioan Puscas
Iuliana Carmen Puscas
Marcela Coltau
Gabriela Domuta
Michael Baican
Original Assignee
Ioan Puscas
Iuliana Carmen Puscas
Marcela Coltau
Gabriela Domuta
Michael Baican
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ioan Puscas, Iuliana Carmen Puscas, Marcela Coltau, Gabriela Domuta, Michael Baican filed Critical Ioan Puscas
Application granted granted Critical
Publication of ATE209256T1 publication Critical patent/ATE209256T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98912475T 1997-03-17 1998-03-13 Schnelle krebs-diagnose ATE209256T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RO97-00502A RO114835B1 (ro) 1997-03-17 1997-03-17 Metodă rapidă de diagnostic al cancerelor
PCT/EP1998/001465 WO1998041649A2 (en) 1997-03-17 1998-03-13 Rapid method of cancer diagnosis

Publications (1)

Publication Number Publication Date
ATE209256T1 true ATE209256T1 (de) 2001-12-15

Family

ID=20104983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98912475T ATE209256T1 (de) 1997-03-17 1998-03-13 Schnelle krebs-diagnose

Country Status (13)

Country Link
US (1) US6326161B1 (de)
EP (1) EP0972072B1 (de)
JP (1) JP2001524815A (de)
CN (1) CN1256713A (de)
AT (1) ATE209256T1 (de)
AU (1) AU738843B2 (de)
BR (1) BR9808373A (de)
CA (1) CA2284632A1 (de)
DE (1) DE69803279D1 (de)
EA (1) EA003185B1 (de)
NZ (1) NZ337850A (de)
RO (1) RO114835B1 (de)
WO (1) WO1998041649A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100135980A1 (en) * 2000-10-16 2010-06-03 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy
US7329495B2 (en) * 2004-06-09 2008-02-12 Board Of Regents, The University Of Texas System Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors
RU2284039C2 (ru) * 2004-09-14 2006-09-20 Сергей Леонидович Попов Методика диагностики и лечения пациентов, страдающих поверхностным раком мочевого пузыря
US8455200B2 (en) 2009-10-15 2013-06-04 Traxxsson, Llc Measurement of PKA for cancer detection
US8765387B2 (en) 2010-01-21 2014-07-01 The Research Foundation Of State University Of New York Method of diagnosing Sjogren's disease
GB201009798D0 (en) * 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
EP3211421A1 (de) 2010-09-09 2017-08-30 Traxxsson, LLC Kombinationsverfahren zur krebsdiagnose
JP6343560B2 (ja) * 2012-09-05 2018-06-13 富士フイルム和光純薬株式会社 乳癌の判定方法
CN104630380B (zh) * 2015-03-06 2016-08-24 河北医科大学第四医院 碳酸酐酶iv在制备肺腺癌诊断制剂中的应用
TWI582240B (zh) * 2015-05-19 2017-05-11 鄭鴻鈞 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置
CN105785004B (zh) * 2016-03-31 2017-11-10 中国医学科学院北京协和医院 细胞分裂周期相关蛋白2在胰腺癌诊断或预后中的用途
CN108287239B (zh) * 2017-12-08 2020-07-17 福建医科大学附属第一医院 血清ca2蛋白在制备肝癌诊断或预后评估试剂盒中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5915858A (ja) * 1982-07-16 1984-01-26 Otsuka Pharmaceut Co Ltd 腫瘍関連抗原特異的免疫複合体の測定法
WO1994009363A1 (en) * 1992-10-14 1994-04-28 Board Of Regents, The University Of Texas System Cancer diagnosis and therapy
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma

Also Published As

Publication number Publication date
DE69803279D1 (de) 2002-02-21
EA003185B1 (ru) 2003-02-27
WO1998041649A3 (en) 1998-12-23
JP2001524815A (ja) 2001-12-04
CN1256713A (zh) 2000-06-14
AU6729898A (en) 1998-10-12
EP0972072B1 (de) 2001-11-21
EP0972072A2 (de) 2000-01-19
RO114835B1 (ro) 1999-07-30
AU738843B2 (en) 2001-09-27
EA199900775A1 (ru) 2000-06-26
BR9808373A (pt) 2000-05-23
WO1998041649A2 (en) 1998-09-24
CA2284632A1 (en) 1998-09-24
US6326161B1 (en) 2001-12-04
NZ337850A (en) 2001-07-27

Similar Documents

Publication Publication Date Title
ATE209256T1 (de) Schnelle krebs-diagnose
DE69937368D1 (de) Nachweis von erkrankungen der nieren und behandlung
IL84866A0 (en) Method for detecting tumors
BR9807734A (pt) Composto para imunodiagnose de câncer de próstata e métodos para o uso dos memos
ATE498838T1 (de) Elektronische verfahren und vorrichtung zum nachweis von analyten
MX9604183A (es) Metodo de examen para identificar ligandos para proteinas objetivo.
NO985150D0 (no) Antigenbindende fragment som sµrlig sporer kreftceller, nukleoid som koder nevnte fragment, samt bruk av dette ved forebygging og pÕvisning av kreft
DE69737788D1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
DE3481775D1 (de) Verfahren zum raschen nachweis von mikroorganismen in klinischen proben.
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
BR8606860A (pt) Processo de imunoensaio para detectar antigeno associado de um carcinoma humano em uma amostra patologica,conjunto para teste de imunoensaio,teste de imunoensaio e processo para identificar marcadores de tumores sosidos em tecido neoplastico
DK130387A (da) Transglutaminase inhibitorer
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
DE69001972D1 (de) Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.
EP1045027A4 (de) Neues gen mit einem revers-transkriptase-motiv
BR9609026A (pt) Composição processo para o tratamento do cáncer e de detecção para a produção de citicina por tumores para determinar a eficácia de um autólogo e kit diagnóstico para detecção para eficácia de compostos celulares autólogos
AT373397B (de) Verfahren zum immunologischen nachweis von krebs in menschlichen geweben
DE69621837D1 (de) Methoden zur feststellung von alzheimerscher krankheit
DK0495910T3 (da) Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer
EP0057236A4 (de) Verfahren zum feststellen der tumorgebundenen glukoseseitenkette, verfahren zur diagnose von tumoren sowie "kit" dazu.
DE69018617D1 (de) Derivate von hydroxymethoxymandelsäure (hmma) und homovanillsäure (hva) und daraus hergestellte antikörper und markierte stoffe sowie diese verwendende immunologische analysen.
ATE135468T1 (de) Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen
DE69739653D1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten
Larralde et al. Porphyrin content of the cysticercus of Taenia solium

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties